NVE Corp. Q3 contract research and development revenue up over fourfold to USD 0.45 million

Reuters01-22
NVE Corp. Q3 contract research and development revenue up over fourfold to USD 0.45 million

NVE Corporation reported financial results for the third quarter (Q3) ended December 31, 2025. Total revenue for Q3 rose 23 percent to USD 6.2 million, driven by a 16 percent increase in product sales and contract research and development revenue that was more than three times higher year over year. Net income for the quarter was USD 3.4 million, an increase of 11 percent, with diluted earnings per share at USD 0.70. For the first nine months (9M) of fiscal 2026, total revenue was USD 18.7 million, up 0.4 percent. Net income for the nine-month period was USD 10.3 million, with diluted earnings per share at USD 2.12. The company also announced a quarterly cash dividend of USD 1.00 per share, payable on February 27, 2026, to shareholders of record as of February 2, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NVE Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001376474-26-000058), on January 21, 2026, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment